Fear of cancer recurrence among Brazilian patients with cancer: Translation and cultural adaptation of FCR4/7 and FCRI-SF measures

Bergerot, Cristiane Decat; Ferreira, Leticia Norata; Molina, Lorena Nascimento Manrique; Pagung, Larissa Bessert; Pedersen, Bianca da Silva; Andrade, Thais Gonçalves de; Machado, Raquel Helena Iinuma; Freitas, Alici Natalia de Sousa; Barreto, Lucia Helena Cavalcanti Toscano; Araujo, Luciana Lima de; Tumeh, Isabella Barros Rabelo Gontijo; Vieira, Natalia Barros Salgado; Lee, David; Philip, Errol J.; Neto, João Nunes Matos; Buso, Marco Murilo; Simard, Sébastien; Ozakinci, Gözde; Humphris, Gerry; Bergerot, Paulo Gustavo; Smith, Allan

doi:10.1016/j.jpsychores.2022.111125

Cited by 4 publications

(2 citation statements)

References 22 publications

(26 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A cutoff score of 17 or above reflects moderate fear of cancer recurrence, and a score of 27 or above indicates severe fear of cancer recurrence. The measure demonstrates good internal consistency (Cronbach α=.92) and validity as compared to measures of anxiety and depression [48].…”

Section: Outcome Measuresmentioning

confidence: 98%

Survivorship Care for Women Living With Ovarian Cancer: Protocol for a Randomized Controlled Trial

Kvale,

Phillips,

Ghosh

et al. 2024

JMIR Res Protoc

View full text Add to dashboard Cite

Background Ovarian cancer ranks 12th in cancer incidence among women in the United States and 5th among causes of cancer-related death. The typical treatment of ovarian cancer focuses on disease management, with little attention given to the survivorship needs of the patient. Qualitative work alludes to a gap in survivorship care; yet, evidence is lacking to support the delivery of survivorship care for individuals living with ovarian cancer. We developed the POSTCare survivorship platform with input from survivors of ovarian cancer and care partners as a means of delivering patient-centered survivorship care. This process is framed by the chronic care model and relevant behavioral theory. Objective The overall goal of this study is to test processes of care that support quality of life (QOL) in survivorship. The specific aims are threefold: first, to test the efficacy of the POSTCare platform in supporting QOL, reducing depressive symptom burden, and reducing recurrence worry. In our second aim, we will examine factors that mediate the effect of the intervention. Our final aim focuses on understanding aspects of care platform design and delivery that may affect the potential for dissemination. Methods We will enroll 120 survivors of ovarian cancer in a randomized controlled trial and collect data at 12 and 24 weeks. Each participant will be randomized to either the POSTCare platform or the standard of care process for survivorship. Our population will be derived from 3 clinics in Texas; each participant will have received some combination of treatment modalities; continued maintenance therapy is not exclusionary. Results We will examine the impact of the POSTCare-O platform on QOL at 12 weeks after intervention as the primary end point. We will look at secondary outcomes, including depressive symptom burden, recurrence anxiety, and physical symptom burden. We will identify mediators important to the impact of the intervention to inform revisions of the intervention for subsequent studies. Data collection was initiated in November 2023 and will continue for approximately 2 years. We expect results from this study to be published in early 2026. Conclusions This study will contribute to the body of survivorship science by testing a flexible platform for survivorship care delivery adapted for the specific survivorship needs of patients with ovarian cancer. The completion of this project will contribute to the growing body of science to guide survivorship care for persons living with cancer. Trial Registration ClinicalTrials.gov NCT05752448; https://clinicaltrials.gov/study/NCT05752448 International Registered Report Identifier (IRRID) PRR1-10.2196/48069

show abstract

Section: Outcome Measuresmentioning

confidence: 98%

Survivorship Care for Women Living With Ovarian Cancer: Protocol for a Randomized Controlled Trial

Kvale,

Phillips,

Ghosh

et al. 2024

JMIR Res Protoc

View full text Add to dashboard Cite

show abstract

“…It has been suggested that cancer outpatients receiving care are adversely confronted with the fear of cancer recurrence (FCR), which significantly influences their QoL [52]. A high degree of attention, high levels of anxiety, persistence, and hypervigilance to visible symptoms are hallmarks of clinical FCR [53,54]. Although feeling apprehensive in the face of risks like cancer is normal, some patients experience extreme anxiety that makes it difficult for them to go about their daily lives.…”

Section: Crc-associated Pain and Their Possible Palliative Strategies...mentioning

confidence: 99%

The Impact of Palliative Care on Mitigating Pain and Its Associated Effects in Determining Quality of Life among Colon Cancer Outpatients

Macharia,

Raposa,

Sipos

et al. 2023

Healthcare

View full text Add to dashboard Cite

Pain continues to be a significant problem for cancer patients, and the impact of a population-based strategy on their experiences is not completely understood. Our study aimed to determine the impact of palliative care on mitigating pain and its associated effects in determining the quality of life (QoL) among colon cancer outpatients. Six collection databases were used to perform a structured systematic review of the available literature, considering all papers published between the year 2000 and February 2023. PRISMA guidelines were adopted in our study, and a total of 9792 papers were evaluated. However, only 126 articles met the inclusion criteria. A precise diagnosis of disruptive colorectal cancer (CRC) pain disorders among patients under palliative care is necessary to mitigate it and its associated effects, enhance health, promote life expectancy, increase therapeutic responsiveness, and decrease comorbidity complications. Physical activities, the use of validated pain assessment tools, remote outpatient education and monitoring, chemotherapeutic pain reduction strategies, music and massage therapies, and bridging social isolation gaps are essential in enhancing QoL. We recommend and place a strong emphasis on the adoption of online training/or coaching programs and the integration of formal and informal palliative care systems for maximum QoL benefits among CRC outpatients.

show abstract

Exercising and immuno-oncology treatment (ExIO): a prospective pilot study for patients with solid tumors

Bergerot,

Silva

et al. 2024

Support Care Cancer

View full text Add to dashboard Cite

Fear of cancer recurrence among Brazilian patients with cancer: Translation and cultural adaptation of FCR4/7 and FCRI-SF measures

Cited by 4 publications

References 22 publications

Survivorship Care for Women Living With Ovarian Cancer: Protocol for a Randomized Controlled Trial

Survivorship Care for Women Living With Ovarian Cancer: Protocol for a Randomized Controlled Trial

The Impact of Palliative Care on Mitigating Pain and Its Associated Effects in Determining Quality of Life among Colon Cancer Outpatients

Exercising and immuno-oncology treatment (ExIO): a prospective pilot study for patients with solid tumors

Contact Info

Product

Resources

About